Freedom Day Solutions, LLC Abb Vie Inc. Transaction History

Freedom Day Solutions, LLC

  • $319 Million
  • Q3 2024

A detailed history of Freedom Day Solutions, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Freedom Day Solutions, LLC holds 11,993 shares of ABBV stock, worth $2.11 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
11,993
Previous 12,161 1.38%
Holding current value
$2.11 Million
Previous $2.09 Million 13.57%
% of portfolio
0.74%
Previous 0.71%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$163.84 - $199.33 $27,525 - $33,487
-168 Reduced 1.38%
11,993 $2.37 Million
Q2 2024

Jul 19, 2024
SELL
$154.79 - $180.76 $91,016 - $106,286
-588 Reduced 4.61%
12,161 $2.09 Million
Q1 2024

Apr 24, 2024
SELL
$159.82 - $182.1 $82,626 - $94,145
-517 Reduced 3.9%
12,749 $2.32 Million
Q4 2023

Jan 29, 2024
SELL
$137.6 - $154.97 $42,793 - $48,195
-311 Reduced 2.29%
13,266 $2.06 Million
Q3 2023

Oct 25, 2023
SELL
$133.59 - $154.65 $82,291 - $95,264
-616 Reduced 4.34%
13,577 $2.02 Million
Q2 2023

Jul 24, 2023
SELL
$132.51 - $164.9 $215,726 - $268,457
-1,628 Reduced 10.29%
14,193 $1.91 Million
Q1 2023

Apr 24, 2023
SELL
$144.61 - $166.54 $105,420 - $121,407
-729 Reduced 4.4%
15,821 $2.52 Million
Q4 2022

Feb 07, 2023
SELL
$138.31 - $165.87 $102,902 - $123,407
-744 Reduced 4.3%
16,550 $2.68 Million
Q3 2022

Oct 28, 2022
SELL
$134.21 - $153.93 $87,504 - $100,362
-652 Reduced 3.63%
17,294 $2.32 Million
Q2 2022

Jul 22, 2022
SELL
$137.62 - $174.96 $91,242 - $115,998
-663 Reduced 3.56%
17,946 $2.75 Million
Q1 2022

May 04, 2022
SELL
$131.98 - $163.75 $69,421 - $86,132
-526 Reduced 2.75%
18,609 $3.02 Million
Q4 2021

Feb 08, 2022
SELL
$107.43 - $135.93 $24,816 - $31,399
-231 Reduced 1.19%
19,135 $2.59 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $104,378 - $118,485
-981 Reduced 4.82%
19,366 $2.09 Million
Q2 2021

Aug 13, 2021
SELL
$105.21 - $117.21 $136,036 - $151,552
-1,293 Reduced 5.98%
20,347 $2.29 Million
Q1 2021

May 10, 2021
BUY
$102.3 - $112.62 $43,272 - $47,638
423 Added 1.99%
21,640 $2.34 Million
Q4 2020

Jan 28, 2021
BUY
$80.49 - $108.67 $151,401 - $204,408
1,881 Added 9.73%
21,217 $2.27 Million
Q3 2020

Oct 26, 2020
BUY
$85.91 - $100.83 $132,301 - $155,278
1,540 Added 8.65%
19,336 $1.69 Million
Q2 2020

Jul 27, 2020
BUY
$73.37 - $98.18 $267,727 - $358,258
3,649 Added 25.79%
17,796 $1.75 Million
Q1 2020

Apr 10, 2020
BUY
$64.5 - $97.79 $368,166 - $558,185
5,708 Added 67.64%
14,147 $1.08 Million
Q4 2019

Jan 21, 2020
BUY
$72.13 - $90.25 $218,265 - $273,096
3,026 Added 55.9%
8,439 $747,000
Q3 2019

Oct 22, 2019
SELL
$62.98 - $75.72 $129,297 - $155,453
-2,053 Reduced 27.5%
5,413 $410,000
Q2 2019

Jul 22, 2019
SELL
$65.7 - $83.98 $68,328 - $87,339
-1,040 Reduced 12.23%
7,466 $543,000
Q1 2019

Apr 26, 2019
SELL
$77.14 - $90.79 $75,211 - $88,520
-975 Reduced 10.28%
8,506 $685,000
Q4 2018

Jan 28, 2019
SELL
$77.85 - $96.01 $123,080 - $151,791
-1,581 Reduced 14.29%
9,481 $874,000
Q3 2018

Oct 15, 2018
SELL
$88.91 - $98.84 $1.14 Million - $1.27 Million
-12,858 Reduced 53.75%
11,062 $1.05 Million
Q2 2018

Jul 12, 2018
BUY
$89.78 - $106.23 $41,568 - $49,184
463 Added 1.97%
23,920 $2.22 Million
Q1 2018

Apr 13, 2018
BUY
$92.01 - $123.21 $1.16 Million - $1.56 Million
12,651 Added 117.07%
23,457 $2.22 Million
Q4 2017

Feb 07, 2018
BUY
$89.56 - $98.21 $967,785 - $1.06 Million
10,806
10,806 $1.05 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Freedom Day Solutions, LLC Portfolio

Follow Freedom Day Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Day Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email